- Home
- GROV vs MODD Comparison
GROV vs MODD Comparison
Compare GROV & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GROV | MODD |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | United States | United States |
| Employees | 295 | N/A |
| Industry | Package Goods/Cosmetics | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.1M | 28.5M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | GROV | MODD |
|---|---|---|
| Price | $1.07 | $2.65 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.60 | N/A |
| AVG Volume (30 Days) | 45.5K | ★ 135.1K |
| Earning Date | 05-07-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.81 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.05 | $0.12 |
| 52 Week High | $1.60 | $6.16 |
Technical Indicators
Market Signals| Indicator | GROV | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 29.81 |
| Support Level | N/A | $0.31 |
| Resistance Level | $1.33 | $5.84 |
| Average True Range (ATR) | 0.09 | 0.51 |
| MACD | -0.01 | -0.18 |
| Stochastic Oscillator | 11.32 | 1.60 |
Price Performance
Historical ComparisonAbout GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with a human and environmental focus. The Company sells its products through a direct-to-consumer (DTC) platform and the Company's mobile applications, where the Company sells products from Grove-owned brands (Grove Brands) and third-parties.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.